$Cassava Sciences (SAVA.US)$ The shorts & FUD people who try...
$Cassava Sciences(SAVA.US$ The shorts & FUD people who try so hard to dissuade the public from SAVA, SAVA has been in agreement with the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for both of its pivotal Phase 3 studies of oral simufilam for the treatment of patients with Alzheimer’s disease. "These SPA agreements document that FDA has reviewed and agreed upon the key design features of Cassava Sciences’ Phase 3 study protocols of simufilam for the treatment of patients with Alzheimer’s disease."
Cognition improvement, slowing decline and well-tolerated is a major benefit on a debilitating disease!!!
Cognition improvement, slowing decline and well-tolerated is a major benefit on a debilitating disease!!!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
